These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elements in the long terminal repeat of HIV-1 that interact with nuclear extracts from Jurkat cells persistently infected with vaccinia virus. Chang PY; Stellrecht K; Melana S; Pogo BG Virus Res; 1994 Nov; 34(2):127-38. PubMed ID: 7856307 [TBL] [Abstract][Full Text] [Related]
3. Regulation of IL-2 gene expression and nuclear factor-90 translocation in vaccinia virus-infected cells. Langland JO; Kao P; Jacobs BL J Interferon Cytokine Res; 2003 Sep; 23(9):489-500. PubMed ID: 14565858 [TBL] [Abstract][Full Text] [Related]
4. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Feske S; Müller JM; Graf D; Kroczek RA; Dräger R; Niemeyer C; Baeuerle PA; Peter HH; Schlesier M Eur J Immunol; 1996 Sep; 26(9):2119-26. PubMed ID: 8814256 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770 [TBL] [Abstract][Full Text] [Related]
6. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237 [TBL] [Abstract][Full Text] [Related]
7. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. Márquez N; Sancho R; Macho A; Calzado MA; Fiebich BL; Muñoz E J Pharmacol Exp Ther; 2004 Mar; 308(3):993-1001. PubMed ID: 14617683 [TBL] [Abstract][Full Text] [Related]
8. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841 [TBL] [Abstract][Full Text] [Related]
9. Characterization of NF(P), the nuclear factor that interacts with the regulatory P sequence (5'-CGAAAATTTCC-3') of the human interleukin-4 gene: relationship to NF-kappa B and NF-AT. Matsuda I; Masuda ES; Tsuboi A; Behnam S; Arai N; Arai K Biochem Biophys Res Commun; 1994 Mar; 199(2):439-46. PubMed ID: 8135784 [TBL] [Abstract][Full Text] [Related]
10. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. Beiqing L; Chen M; Whisler RL J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110 [TBL] [Abstract][Full Text] [Related]
11. Early immune response and regulation of IL-2 receptor subunits. Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752 [TBL] [Abstract][Full Text] [Related]
12. Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus. Stellrecht KA; Sperber K; Pogo BG J Virol; 1992 Apr; 66(4):2051-6. PubMed ID: 1548751 [TBL] [Abstract][Full Text] [Related]
13. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Jabado N; Le Deist F; Fisher A; Hivroz C Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556 [TBL] [Abstract][Full Text] [Related]
14. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency. Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578 [TBL] [Abstract][Full Text] [Related]
15. CREB and COUP-TF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in Jurkat T cells in response to cyclic AMP and dopamine. Rohr O; Schwartz C; Aunis D; Schaeffer E J Cell Biochem; 1999 Dec; 75(3):404-13. PubMed ID: 10536364 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of lymphokines in Jurkat cells persistently infected with vaccinia virus. Stellrecht KA; Sperber K; Pogo BG J Virol; 1992 Apr; 66(4):2046-50. PubMed ID: 1347794 [TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice. Perera LP; Goldman CK; Waldmann TA Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5146-51. PubMed ID: 11296252 [TBL] [Abstract][Full Text] [Related]
18. Stability of vaccinia virus DNA during persistent infections: accumulation of left-end deletions and of tandem repeats at both ends of the viral genome and prevention by interferon. Paez E; Esteban M Virology; 1988 Mar; 163(1):145-54. PubMed ID: 3347996 [TBL] [Abstract][Full Text] [Related]
19. Changes in cell gene expression in human leukemic cells persistently infected with vaccinia virus. Pogo BG; Lai AC; Joesten ME; Royston ME; Holloway D Virus Res; 1991 May; 19(2-3):131-8. PubMed ID: 1891958 [TBL] [Abstract][Full Text] [Related]
20. [Advances in application of Jurkat cell model in research on infectious diseases]. Chen JL; Nong GM Zhongguo Dang Dai Er Ke Za Zhi; 2018 Mar; 20(3):236-242. PubMed ID: 29530126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]